For the purpose of this study, cell lines with an IC50 of ≤56 nM, including the two ALK+ALCL cell lines and NB1, were considered Crizotinib-sensitive; the other 4 cell lines that carried an IC50 of >56 nM were considered Crizotinib-resistant. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.